Anne O’Neill

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer”.

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.0254

N/A

0.488DataRank · unranked

7 citations

Anne O’Neill, Karen Sepucha, Kathy D. Miller, Chau T. Dang, Donald W. Northfelt +4 more

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07417-4

N/A

0.215DataRank · unranked

3 citations

Anne O’Neill, Ingrid A. Mayer, Carlos L. Arteaga, Ximing J. Yang, Lynne I. Wagner +17 more

Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7018

N/A

0.203DataRank · unranked

2 citations

Yael Flamand, Naomi B. Haas, Anne O’Neill, Robert S. DiPaola, Pearl Subramanian +6 more

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07519-z

N/A

0.174DataRank · unranked

2 citations

Anne O’Neill, Bryan P. Schneider, Todd C. Skaar, Minetta C. Liu, Caroline Lohrisch +9 more

Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE

British Journal of Cancer(2024)10.1038/s41416-024-02602-0

N/A

0DataRank · unranked

0 citations

Guanglong Jiang, Santosh Philips, Erica Cantor, Laura Gardner, Gloria Xue +9 more

A catalog of associations between rare coding variants and COVID-19 outcomes

medRxiv(2020)10.1101/2020.10.28.20221804

N/A

0DataRank · unranked

31 citations

Julie Horowitz, Nilanjana Banerjee, Rouel Lanche, Anthony Marcketta, Evan K. Maxwell +75 more

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Research Square(2024)10.21203/rs.3.rs-4295044/v1

N/A

0DataRank · unranked

0 citations

Anne O’Neill, Ingrid A. Mayer, Carlos L. Arteaga, Ximing J. Yang, Lynne I. Wagner +17 more

Social determinants of health, genetic ancestry, and mortality in ECOG-ACRIN E5103.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6527

N/A

0DataRank · unranked

3 citations

Anne O’Neill, Kathy D. Miller, Bryan P. Schneider, Ann H. Partridge, Lava Timsina +4 more

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.520

N/A

0DataRank · unranked

2 citations

Anne O’Neill, Noah Graham, Donald W. Northfelt, Chau T. Dang, Antonio C. Wolff +3 more

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

npj Breast Cancer(2022)10.1038/s41523-021-00376-9

N/A

0DataRank · unranked

27 citations

Anne O’Neill, Noah Graham, Donald W. Northfelt, Chau T. Dang, Antonio C. Wolff +3 more